APPLICATION
ANDA075240
TYPE
ANDA
ORIGINAL APPROVAL
1999-11-29
LATEST ACTION
2015-11-17
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
LABETALOL HYDROCHLORIDEPrescription
LABETALOL HYDROCHLORIDE 5MG/ML · INJECTABLE · INJECTION
Approval history
2015-11-17Labeling · Supplement 13 · standardAP
2015-11-17Labeling · Supplement 12 · standardAP
2012-09-04Labeling · Supplement 10AP
2001-02-14Manufacturing (CMC) · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.